InsightfulValue
← Home

Merck
Merck

-4.8%

Pharma / Pharma


πŸ”§ Tools

βœ… Due Diligence
Company at a Glance

More reviews (1)
Merck

πŸ“Š Get full analytics about Merck

Sign up for free or log in

πŸ”“ Unlock our free guide: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

Price
Live  
Infographic
Infographics
Overview
Merck is a global pharmaceutical and chemical company founded in 1668 in Darmstadt, Germany. It was originally a supplier of traditional chemicals, but later expanded into pharmaceuticals, life sciences, and performance materials. Merck is also known as Merck KGaA, as it is a family-owned company with around 50% of its shares controlled by the descendants of its founder, Friedrich Jacob Merck.
The company has a strong presence in Europe and the United States, as well as in emerging markets such as China, India, and Latin America. It employs over 57,000 people and generates annual revenues of around 14 billion euros.
Merck's pharmaceutical division focuses on developing and commercializing innovative medicines in various therapeutic areas, including oncology, neurology, immunology, and cardiovascular diseases. Its life sciences division provides products and services for research, development, and production in the biopharmaceutical and biotechnological industries. The performance materials division provides materials and technologies for various industries, including healthcare, electronics, coatings, and cosmetics.
The company's mission is to "empower scientists and engineers to create and make life-changing innovations that improve people's lives." It is committed to sustainability and has set ambitious targets to reduce its environmental impact, promote diversity and inclusion, and improve access to healthcare for underserved populations.
Merck is also actively involved in corporate social responsibility initiatives, including providing disaster relief and supporting education and community development programs around the world.
What is special about the company?
Merck

πŸ“ˆ Want to read more about Merck?

Sign up for free or log in

✍️ Sign up to get "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" for free

TWVyY2sgaX MgYSBnbG9i YWwgcGhhcm 1hY2V1dGlj YWwgYW5kIG hlYWx0aGNh cmUgY29tcG FueSB0aGF0 IGhhcyBiZW VuIGluIG9w ZXJhdGlvbi Bmb3Igb3Zl ciAzNTAgeW VhcnMsIG1h a2luZyBpdC BvbmUgb2Yg dGhlIG9sZG VzdCBhbmQg bGFyZ2VzdC BwaGFybWFj ZXV0aWNhbC Bjb21wYW5p ZXMgaW4gdG hlIHdvcmxk LiBJdCBoYX MgYSBsb25n IGhpc3Rvcn kgb2YgaW5u b3ZhdGlvbi BhbmQgcmVz ZWFyY2gsIG xlYWRpbmcg dG8gdGhlIG RldmVsb3Bt ZW50IG9mIG 51bWVyb3Vz IG1lZGljYX Rpb25zIGFu ZCB2YWNjaW 5lcyB0aGF0 IGhhdmUgc2 lnbmlmaWNh bnRseSBpbX Byb3ZlZCBn bG9iYWwgaG VhbHRoLiBU aGUgY29tcG FueSBhbHNv IGhhcyBhIH N0cm9uZyBj b21taXRtZW 50IHRvIHN1 c3RhaW5hYm lsaXR5IGFu ZCBjb3Jwb3 JhdGUgcmVz cG9uc2liaW xpdHksIGVt cGhhc2l6aW 5nIGV0aGlj YWwgYnVzaW 5lc3MgcHJh Y3RpY2VzIG FuZCBnaXZp bmcgYmFjay B0byB0aGUg Y29tbXVuaX RpZXMgaW4g d2hpY2ggaX Qgb3BlcmF0 ZXMuIE1lcm NrIGlzIGFs c28ga25vd2 4gZm9yIGl0 cyBkaXZlcn NlIHdvcmtm b3JjZSBhbm QgaW5jbHVz aXZlIGN1bH R1cmUsIHdp dGggYSBmb2 N1cyBvbiBw cm9tb3Rpbm cgZGl2ZXJz aXR5IGFuZC BpbmNsdXNp b24gaW4gYW xsIGFzcGVj dHMgb2YgaX RzIG9wZXJh dGlvbnMuIE FkZGl0aW9u YWxseSwgTW VyY2sgaGFz IGEgc3Ryb2 5nIGZvY3Vz IG9uIHJlc2 VhcmNoIGFu ZCBkZXZlbG 9wbWVudCBh bmQgaW52ZX N0cyBoZWF2 aWx5IGluIG 5ldyB0ZWNo bm9sb2dpZX MgYW5kIGlu bm92YXRpb2 5zIHRvIGNv bnRpbnVlIG RyaXZpbmcg c2NpZW50aW ZpYyBhZHZh bmNlbWVudH MgaW4gdGhl IGhlYWx0aG NhcmUgaW5k dXN0cnkuIE 92ZXJhbGws IE1lcmNrJ3 MgZGVkaWNh dGlvbiB0by BpbXByb3Zp bmcgZ2xvYm FsIGhlYWx0 aCwgY29tbW l0bWVudCB0 byBldGhpY2 FsIGFuZCBy ZXNwb25zaW JsZSBidXNp bmVzcyBwcm FjdGljZXMs IGFuZCBlbX BoYXNpcyBv biBkaXZlcn NpdHkgYW5k IHJlc2Vhcm NoIG1ha2Ug aXQgYSB1bm lxdWUgYW5k IHJlc3BlY3 RlZCBjb21w YW55IGluIH RoZSBwaGFy bWFjZXV0aW NhbCBpbmR1 c3RyeS4=
What the company's business model?
Merck

πŸ“ˆ Want to read more about Merck?

Sign up for free or log in

⚑ Instantly access "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free!

VGhlIE1lcm NrIGNvbXBh bnkgaXMgYS BnbG9iYWwg cGhhcm1hY2 V1dGljYWwg Y29tcGFueS B0aGF0IG9w ZXJhdGVzIH VuZGVyIGEg dHJhZGl0aW 9uYWwgYnVz aW5lc3MgbW 9kZWwuIFRo aXMgbWVhbn MgdGhhdCBp dCBjcmVhdG VzLCBtYW51 ZmFjdHVyZX MsIGFuZCBt YXJrZXRzIH ByZXNjcmlw dGlvbiBkcn VncywgdmFj Y2luZXMsIG Jpb2xvZ2lj IHRoZXJhcG llcywgYW5p bWFsIGhlYW x0aCBwcm9k dWN0cywgYW 5kIG92ZXIt dGhlLWNvdW 50ZXIgbWVk aWNhdGlvbn MuIFRoZSBj b21wYW55J3 MgbWFpbiBy ZXZlbnVlIH NvdXJjZSBp cyB0aHJvdW doIHRoZSBz YWxlIG9mIH RoZXNlIHBy b2R1Y3RzIH RvIGhlYWx0 aCBjYXJlIH Byb2Zlc3Np b25hbHMgYW 5kIGRpcmVj dGx5IHRvIG NvbnN1bWVy cy4gTWVyY2 sgYWxzbyBl bmdhZ2VzIG luIHJlc2Vh cmNoIGFuZC BkZXZlbG9w bWVudCBvZi BuZXcgbWVk aWNpbmVzLC BhbmQgaGFz IGEgbGFyZ2 UgcG9ydGZv bGlvIG9mIH Byb2R1Y3Rz IGZvY3VzZW Qgb24gdGhl cmFwZXV0aW MgYXJlYXMg c3VjaCBhcy BvbmNvbG9n eSwgY2FyZG lvdmFzY3Vs YXIgZGlzZW FzZXMsIHZh Y2NpbmVzLC BpbmZlY3Rp b3VzIGRpc2 Vhc2VzLCBh bmQgYW5pbW FsIGhlYWx0 aC4gSW4gYW RkaXRpb24g dG8gZGV2ZW xvcGluZyBh bmQgc2VsbG luZyBpdHMg b3duIHByb2 R1Y3RzLCBN ZXJjayBhbH NvIGVuZ2Fn ZXMgaW4gcG FydG5lcnNo aXBzIGFuZC Bjb2xsYWJv cmF0aW9ucy B3aXRoIG90 aGVyIGNvbX BhbmllcyBp biB0aGUgaG VhbHRoY2Fy ZSBpbmR1c3 RyeS4=
Sensitivity to interest rates
The sensitivity of Merck & Co.’s earnings, cash flow, and valuation to changes in interest rates can be analyzed through several factors:
1. Earnings Sensitivity: Merck’s earnings are indirectly sensitive to interest rates. Higher interest rates can lead to increased borrowing costs if the company needs to finance operations, research and development, or acquisitions. Additionally, higher rates may constrain consumer spending, potentially impacting sales of pharmaceuticals. Conversely, lower interest rates may facilitate capital investment and expansion.
2. Cash Flow Sensitivity: Merck’s cash flow can be affected by interest rates primarily through its debt obligations. If interest rates rise, the cost of servicing any variable-rate debt will increase, potentially reducing free cash flow. Lower rates can positively impact cash flow by lowering interest expenses. Moreover, changes in interest rates can influence the timing and amount of cash flows received from customers, especially in a tight economic environment.
3. Valuation Sensitivity: The valuation of Merck, like other companies, is sensitive to changes in interest rates due to the discounted cash flow (DCF) methodology generally used to estimate a company’s value. When interest rates rise, the discount rate used in DCF calculations increases, which can lead to a lower present value of future cash flows, thus reducing the company’s valuation. Conversely, lower interest rates can enhance valuation by lowering the discount rate and increasing the present value of future cash flows.
In summary, while Merck’s operations can be influenced by changes in interest rates, the sensitivity may not be as pronounced as in highly leveraged companies. The impact on earnings, cash flow, and valuation will depend on the company’s debt levels, capital structure, and market dynamics.
Interesting facts about the company
Merck

πŸ“ˆ Want to read more about Merck?

Sign up for free or log in

πŸ“₯ Get our free eBook now: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvNX owZmx5ZTJB cEZ0SVRRMD FCZFkud2Vi cCIgYWx0PS JNZXJjayIg dGl0bGU9Ik 1lcmNrIiAg Y2xhc3M9Im ltZy1mbHVp ZCIgaGVpZ2 h0PTkwIHdp ZHRoPTkwIG xvYWRpbmc9 J2xhenknIH N0eWxlPSdi b3JkZXItcm FkaXVzOiA2 cHg7Jz4KCi AgICAgICAg ICAgICAgIC AgICAgPGRp diBzdHlsZT 0nZmxleDog MTsgdGV4dC 1hbGlnbjog Y2VudGVyOy BtYXJnaW4t bGVmdDogNX B4Oyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID xwIHN0eWxl PSdmb250LX NpemU6IDI2 cHg7IGNvbG 9yOiAjMzMz OyBtYXJnaW 4tYm90dG9t OiAxNXB4Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Dwn5OIIFdh bnQgdG8gcm VhZCBtb3Jl IGFib3V0IE 1lcmNrPwog ICAgICAgIC AgICAgICAg ICAgICAgIC A8L3A+Cgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8YSBocmVm PSdpbmRleC 5waHA/cGFn ZT1zaWdudX AnIHN0eWxl PScKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGJhY2tncm 91bmQtY29s b3I6ICMwMD dCRkY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBjb2xv cjogI2ZmZj sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIH BhZGRpbmc6 IDEwcHggMj BweDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGJvcmRl ci1yYWRpdX M6IDVweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRl eHQtZGVjb3 JhdGlvbjog bm9uZTsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGZvbn Qtd2VpZ2h0 OiBib2xkOw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgbW FyZ2luLXJp Z2h0OiAxMH B4OwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgdHJhbnNp dGlvbjogYm Fja2dyb3Vu ZC1jb2xvci AwLjNzIGVh c2U7JwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgb25tb3 VzZW92ZXI9 J3RoaXMuc3 R5bGUuYmFj a2dyb3VuZE NvbG9yPSIj MDA1NmIzIi cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dXQ9J3RoaX Muc3R5bGUu YmFja2dyb3 VuZENvbG9y PSIjMDA3Qk ZGIic+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBTaWdu IHVwIGZvci BmcmVlCiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvYT4KCiAg ICAgICAgIC AgICAgICAg ICAgICAgID xzcGFuIHN0 eWxlPSdtYX JnaW46IDAg OHB4OyBjb2 xvcjogIzU1 NTsnPm9yPC 9zcGFuPgoK ICAgICAgIC AgICAgICAg ICAgICAgIC AgPGEgaHJl Zj0naW5kZX gucGhwP3Bh Z2U9bG9naW 4nIHN0eWxl PScKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg dGV4dC1kZW NvcmF0aW9u OiB1bmRlcm xpbmU7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBmb250 LXdlaWdodD ogNTAwOyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBs b2cgaW4KIC AgICAgICAg ICAgICAgIC AgICAgICAg PC9hPgoKCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxwIHN0eW xlPSdtYXJn aW4tdG9wOi AxNXB4OyBm b250LXNpem U6IDEzcHg7 IGZvbnQtd2 VpZ2h0OiBi b2xkOyBjb2 xvcjogI2Qz MmYyZjsnPg ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAg8J +TmCBDbGFp bSB5b3VyIG ZyZWUgZUJv b2s6IDxpPi JUaGUgQ2hl Y2tsaXN0IF ZhbHVlIElu dmVzdG9yIO KAlCBBIFNt YXJ0ZXIgV2 F5IHRvIFBp Y2sgU3RvY2 tzIjwvaT4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9wPgoK ICAgICAgIC AgICAgICAg ICAgICAgIC AgPCEtLQog ICAgICAgIC AgICAgICAg ICAgICAgIC A8ZGl2IHN0 eWxlPSdtYX JnaW4tdG9w OiAxMnB4Oy Bmb250LXNp emU6IDEzcH g7IGNvbG9y OiAjNDQ0Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC BTaWduIHVw IG5vdyBhbm QgZ2V0IG91 ciBmcmVlIG VCb29rIAog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgPGI+ VGhlIENoZW NrbGlzdCBW YWx1ZSBJbn Zlc3RvciDi gJQgQSBTbW FydGVyIFdh eSB0byBQaW NrIFN0b2Nr czwvYj4KIC AgICAgICAg ICAgICAgIC AgICAgICAg PC9kaXY+Ci AgICAgICAg ICAgICAgIC AgICAgICAg IC0tPgogIC AgICAgICAg ICAgICAgIC AgICAgICA8 IS0tCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxk aXYgc3R5bG U9J21hcmdp bi10b3A6ID E2cHg7IGZv bnQtc2l6ZT ogMTRweDsg Y29sb3I6IC M0NDQ7IGZv bnQtZmFtaW x5OiAtYXBw bGUtc3lzdG VtLCBCbGlu a01hY1N5c3 RlbUZvbnQs IFNlZ29lIF VJLCBSb2Jv dG8sIEhlbH ZldGljYSBO ZXVlLCBzYW 5zLXNlcmlm OyBsaW5lLW hlaWdodDog MS42Oyc+Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBIYX ZlIHlvdSBo ZWFyZCBhYm 91dCBvdXIg c2hvcnQgPH N0cm9uZyBz dHlsZT0nZm 9udC13ZWln aHQ6IDYwMD snPkRhaWx5 IFZpZGVvIE 5ld3NsZXR0 ZXI8L3N0cm 9uZz4/CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICA8YSBo cmVmPSdodH RwczovL3d3 dy5pbnNpZ2 h0ZnVsdmFs dWUuY29tL2 5ld3NsZXR0 ZXIucGhwJy B0YXJnZXQ9 J19ibGFuay cgc3R5bGU9 J2NvbG9yOi AjMDA3QkZG OyB0ZXh0LW RlY29yYXRp b246IG5vbm U7IGZvbnQt d2VpZ2h0Oi A1MDA7IG1h cmdpbi1sZW Z0OiA2cHg7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBGaW 5kIG91dCBt b3JlCiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICA8L2E+Ci AgICAgICAg ICAgICAgIC AgICAgICAg IDwvZGl2Pg ogICAgICAg ICAgICAgIC AgICAgICAg ICAtLT4KIC AgICAgICAg ICAgICAgIC AgICA8L2Rp dj4KICAgIC AgICAgICAg ICAgIDwvZG l2PgogICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgCiAg ICAgICAgCi AgICAgICAg PHNwYW4gY2 xhc3M9J2Js dXJyZWQtdG V4dCc+CiAg ICAgICAgIC AgIFRXVnlZ MnNnSm0gRn RjRHNnUTI4 dSBMQ0JyYm 05M2JpIEJo Y3lCTlUwUW cgYjNWMGMy bGtaUyBCMG FHVWdWVzVw IGRHVmtJRk 4wWVggUmxj eUJoYm1RZy BRMkZ1WVdS aExDIEJwY3 lCdmJtVWcg YjJZZ2RHaG xJRyB4aGNt ZGxjM1FnIG NHaGhjbTFo WTIgVjFkR2 xqWVd3ZyBZ Mjl0Y0dGdW FXIFZ6SUds dUlIUm8gWl NCM2IzSnNa QyA0Z1NHVn laU0JoIGNt VWdjMjl0Wl MgQnBiblJs Y21WeiBkR2 x1WnlCbVlX IE4wY3lCaF ltOTEgZENC MGFHVWdZMi A5dGNHRnVl VG84IFluSS tNUzRnU0cg bHpkRzl5ZV RvZyBUV1Z5 WTJzZ2QyIE Z6SUc5eWFX ZHAgYm1Gc2 JIa2dabSA5 MWJtUmxaQ0 JwIGJpQXhP RGt4SUcgRn pJSFJvWlNC ViBMbE11SU hOMVluIE5w WkdsaGNua2 cgYjJZZ2RH aGxJRSBkbG NtMWhiaUJO IFpYSmpheU JtWVcgMXBi SGtnWTI5dC BjR0Z1ZVN3 Z2QyIGhwWT JnZ1pHRjAg WlhNZ1ltRm pheSBCMGJ5 QXhOalk0IE xpQlVhR1Vn VlMgNVRMaU JpY21GdSBZ MmdnWW1Wal lXIDFsSUds dVpHVncgWl c1a1pXNTBJ RyBSMWNtbH VaeUJYIGIz SnNaQ0JYWV ggSWdTUzQ4 WW5JKyBNaT RnU1c1dWIz IFpoZEdsdm Jqb2cgVFdW eVkyc2dhRy BGeklHSmxa VzRnIGNtVn pjRzl1YzIg bGliR1VnWm 05eSBJSE5s ZG1WeVlXIH dnWjNKdmRX NWsgWW5KbF lXdHBibSBj Z1pISjFaM0 1nIFlXNWtJ SFpoWTIgTn BibVZ6SUc5 MiBaWElnZE dobElIIGxs WVhKekxDQn AgYm1Oc2RX UnBibSBjZ2 RHaGxJR1Js IGRtVnNiM0 J0WlcgNTBJ RzltSUhSby BaU0JtYVhK emRDIEJ0Wl dGemJHVnog SUhaaFkyTn BibSBVZ2FX NGdkR2hsIE lERTVOakJ6 TEMgQjBhR1 VnU0ZCVyBJ SFpoWTJOcG JtIFVnUjJG eVpHRnogYV d3c0lHRnVa QyBCMGFHVW dZMmh2IGJH VnpkR1Z5Yj Igd3RiRzkz WlhKcCBibW NnWkhKMVp5 IEJhYjJOdm NpNDggWW5J K015NGdVbS BWelpXRnlZ MmdnIFJtOW pkWE02SUUg MWxjbU5ySU dsdSBkbVZ6 ZEhNZ2FHIF ZoZG1sc2VT QnAgYmlCeV pYTmxZWCBK amFDQmhibV FnIFpHVjJa V3h2Y0cgMW xiblF1SUZS byBaU0JqYj Ixd1lXIDU1 SUdoaGN5Qm ggSUd4dmJt Y3RjMyBSaG JtUnBibWNn IFkyOXRiV2 wwYlcgVnVk Q0IwYnlCaC BaSFpoYm1O cGJtIGNnYU dWaGJIUm8g WTJGeVpTQj BhSCBKdmRX ZG9JSE5qIG FXVnVZMlVn WVcgNWtJR2 hoY3lCaCBJ R1JwZG1WeW MyIFVnY0ds d1pXeHAgYm 1VZ2RHaGhk QyBCcGJtTn NkV1JsIGN5 QjBjbVZoZE cgMWxiblJ6 SUdadiBjaU JrYVdGaVpY IFJsY3l3Z1 kyRnUgWTJW eUxDQmhibS BRZ2FXNW1a V04wIGFXOT FjeUJrYVgg TmxZWE5sY3 k0OCBZbkkr TkM0Z1IyIH h2WW1Gc0lG SmwgWVdOb0 9pQk5aWCBK amF5QnZjR1 Z5IFlYUmxj eUJwYmkgQn RiM0psSUhS byBZVzRnTV RRd0lHIE52 ZFc1MGNtbG wgY3l3Z2JX RnJhVyA1bk lHbDBjeUJ3 IGNtOWtkV0 4wY3kgQmhZ Mk5sYzNOcC BZbXhsSUhS dklHIEVnYz JsbmJtbG0g YVdOaGJuUW djRyA5eWRH bHZiaUJ2IF ppQjBhR1Vn WjIgeHZZbU ZzSUhCdiBj SFZzWVhScG IyIDR1SUVs MGN5Qm4gYk c5aVlXd2dj SCBKbGMyVn VZMlVnIFlX eHNiM2R6SU cgWnZjaUJr YVhabCBjbk 5sSUcxaGNt IHRsZEhNZ1 lXNWsgSUhC aGNuUnVaWC BKemFHbHdj eTQ4IFluSS tOUzRnUTIg OXRiV2wwYl dWdSBkQ0Iw YnlCVGRYIE 4wWVdsdVlX SnAgYkdsMG VUb2dUVyBW eVkyc2dhR0 Z6IElHMWha R1VnYzMgUn lhV1JsY3lC cCBiaUJ6ZF hOMFlXIGx1 WVdKc1pTQn cgY21GamRH bGpaWCBNc0 lHRnBiV2x1 IFp5QjBieU J5WlcgUjFZ MlVnYVhSei BJR1Z1ZG1s eWIyIDV0Wl c1MFlXd2cg Wm05dmRIQn lhVyA1MElH RnVaQ0JtIG IyTjFjMmx1 WnkgQnZiaU J5WlhOdyBi MjV6YVdKc1 pTIEJ6YjNW eVkybHUgWn l3Z1pXNWxj bSBkNUlHVm 1abWxqIGFX VnVZM2tzSU cgRnVaQ0Iz WVhOMCBaU0 J5WldSMVkz IFJwYjI0Z2 FXNGcgYVhS eklHMWhibi BWbVlXTjBk WEpwIGJtY2 djSEp2WTIg VnpjMlZ6TG p4aSBjajQy TGlCTlpYIE pqYXlCTllX NTEgWVd3Nk lFMWxjbSBO cklIQjFZbX hwIGMyaGxj eUIwYUcgVW dUV1Z5WTJz ZyBUV0Z1ZF dGc0xDIEJo SUhkcFpHVn MgZVNCeVpY TndaVyBOMF pXUWdiV1Zr IGFXTmhiQ0 J5WlcgWmxj bVZ1WTJVZy BZbTl2YXlC MWMyIFZrSU dKNUlHaGwg WVd4MGFHTm hjbSBVZ2NI SnZabVZ6IG MybHZibUZz Y3kgNGdTWF FnYUdGeiBJ R0psWlc0Z2 FXIDRnY0hW aWJHbGogWV hScGIyNGdj MiBsdVkyVW dNVGc1IE9T QmhibVFnYV ggTWdZWFpo YVd4aCBZbX hsSUdsdUlH IDExYkhScG NHeGwgSUd4 aGJtZDFZVy BkbGN5NDhZ bkkrIE55NG dRMjl5Y0cg OXlZWFJsSU ZOdiBZMmxo YkNCU1pYIE 53YjI1emFX SnAgYkdsMG VUb2dUVyBW eVkyc2dhWE 1nIGFXNTJi MngyWlcgUW dhVzRnZG1G eSBhVzkxY3 lCd2FHIGxz WVc1MGFISn YgY0dsaklH bHVhWCBScF lYUnBkbVZ6 IExDQnBibU 5zZFcgUnBi bWNnWVdOai BaWE56SUhS dklHIDFsWk dsamFXNWwg Y3lCaGJtUW dhRyBWaGJI Um9ZMkZ5IF pTQndjbTlu Y20gRnRjeU JwYmlCMSBi bVJsY25ObG NuIFpsWkNC amIyMXQgZF c1cGRHbGxj eSBCaGNtOT FibVFnIGRH aGxJSGR2Y2 0geGtMaUJV YUdWNSBJR1 p2WTNWeklH IDl1SUcxaG EybHUgWnlC b1pXRnNkRy BoallYSmxJ RzF2IGNtVW daWEYxYVgg UmhZbXhsSU dGdSBaQ0Jo WTJObGMzIE 5wWW14bExq eGkgY2o0NE xpQkJibSBs dFlXd2dTR1 ZoIGJIUm9P aUJKYmkgQm haR1JwZEds diBiaUIwYn lCb2RXIDFo YmlCd2FHRn kgYldGalpY VjBhVyBOaG JITXNJRTFs IGNtTnJJR2 x6SUcgRWdi R1ZoWkdWeS BJR2x1SUha bGRHIFZ5YV c1aGNua2cg YldWa2FXTn BibSBVdUlF MWxjbU5yIE lFRnVhVzFo YkMgQklaV0 ZzZEdnZyBi MlptWlhKek lIIFpoWTJO cGJtVnogSU dGdVpDQndh RyBGeWJXRm paWFYwIGFX TmhiSE1nWm 0gOXlJR3hw ZG1WeiBkRz lqYXlCaGJt IFFnWTI5dG NHRnUgYVc5 dUlHRnVhVy AxaGJITXNJ R052IGJuUn lhV0oxZEcg bHVaeUJ6YV dkdSBhV1pw WTJGdWRHIH g1SUhSdklI WmwgZEdWeW FXNWhjbiBr Z1kyRnlaUz Q4IFluSStP UzRnVTMgUn liMjVuSUZC cCBjR1ZzYV c1bE9pIEJV YUdVZ1kyOX QgY0dGdWVT Qm9ZWCBNZ1 lTQnliMkox IGMzUWdjR2 x3WlcgeHBi bVVnYjJZZy BaSEoxWjNN Z2FXIDRnZG 1GeWFXOTEg Y3lCemRHRm 5aWCBNZ2Iy WWdaR1YyIF pXeHZjRzFs Ym4gUXNJR1 p2WTNWeiBh VzVuSUc5dU lHIEZ5WldG eklITjEgWT JnZ1lYTWdi MiA1amIyeH ZaM2tzIElI WmhZMk5wYm 0gVWdaR1Yy Wld4diBjRz FsYm5Rc0lH IEZ1WkNCcG JtWmwgWTNS cGIzVnpJRy BScGMyVmhj MlZ6IExpQl VhR2x6SUcg TnZiblJwYm 5WdiBkWE1n YVc1dWIzIF poZEdsdmJp QncgYkdGNW N5QmhJRyBO eWRXTnBZV3 dnIGNtOXNa U0JwYmkgQn BkSE1nWjNK diBkM1JvTG p4aWNqIDR4 TUM0Z1JXMX cgYkc5NVpX VWdRMyBWc2 RIVnlaVG9n IFRXVnlZMn NnYVggTWdh MjV2ZDI0Zy BabTl5SUds MGN5IEJqYj IxdGFYUnQg Wlc1MElIUn ZJSCBkdmNt dHdiR0ZqIF pTQmthWFps Y24gTnBkSG tnWVc1ayBJ R1Z0Y0d4dm VXIFZsSUhk bGJHd3QgWW 1WcGJtY3VJ RiBSb1pTQm piMjF3IFlX NTVJR1Z0Y0 cgaGhjMmw2 WlhNZyBZU0 JqZFd4MGRY IEpsSUc5bU lHbHUgWTJ4 MWMybHZiaS BCaGJtUWdj M1Z3IGNHOX lkQ3dnYzMg UnlhWFpwYm 1jZyBkRzhn WTNKbFlYIF JsSUdGdUlH VnUgZG1seW IyNXRaVyA1 MElIZG9aWE psIElHVnRj R3h2ZVcgVm xjeUJqWVc0 ZyBkR2h5YV habExqIHhp Y2o1VWFHVn ogWlNCaGMz QmxZMyBSek lHaHBaMmhz IGFXZG9kQ0 JOWlggSmph K0tBbVhNZy BjMmxuYm1s bWFXIE5oYm 5RZ2FXMXcg WVdOMElHOX VJRyBobFlX eDBhR05oIG NtVXNJSEps YzIgVmhjbU 5vTENCaCBi bVFnWTI5eW NHIDl5WVhS bElISmwgYz NCdmJuTnBZ bSBsc2FYUj VManhpIGNq ND0KICAgIC AgICA8L3Nw YW4+CiAgIC AgICAgCiAg ICAgICAg
See Company Q&A
Merck

πŸ“Š Get full analytics about Merck

Sign up for free or log in

🎁 Free download! "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

© 2024 - 2026 InsightfulValue.com. All rights reserved. Newsletter
Legal